What is Evologics?
Evologics operates within the biologics sector, driven by a core mission to improve lives through advanced healthcare solutions. The company emphasizes a people-first culture, extending from patients and medical professionals to its internal team. Its strategic objective is to create life-saving and life-enhancing treatments by merging cutting-edge innovation with compassionate care, underscoring the value of every individual life. Evologics differentiates itself through its deeply embedded commitment to humanity and the positive impact each person can make.
How much funding has Evologics raised?
Evologics has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
What's next for Evologics?
With significant Series B/C stage funding, Evologics is poised for substantial expansion. The recent influx of capital, described as substantial expansion capital, will likely be directed towards accelerating research and development, scaling manufacturing capabilities, and broadening market reach. This strategic investment suggests a focus on advancing its pipeline of biologics and solidifying its market position as a leader in compassionate, innovation-driven healthcare solutions. The company's trajectory indicates a strong potential for continued growth and impact in the biopharmaceutical industry.
See full Evologics company page
